This story has been corrected from a previous version, which incorrectly stated that Ronald Kahn was a co-founder of RealTime Health. He is on the company's scientific advisory board. 

BETHESDA, Md., Dec 4 – InforMax CEO Alex Titomirov said Tuesday he was launching a new start-up that would make gene expression-based preventive medicine technology available to individuals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.